GNAS and neoplasm: Analysis of pancreatic exocrine secretions may be improved by the inclusion of other mutations known to be associated with particular tumour subtypes including GNAS mutations in intraductal papillary neoplasms of the bile ducts (IPNBs), or von Hippel -Lindau (VHL) mutation in serous cystic neoplasms [44,57,58,59].